Oxford’s Doug Altman Receives Lifetime Achievement Award
Altman has been instrumental in the development of “truly robust guidelines for the reporting of clinical trials and wider clinical research studies”.
Prof. Doug Altman, founding director of the Centre for Statistics in Medicine in Oxford, U.K. has received the 2015 BMJ Lifetime Achievement for his contribution to improving reporting of health research.
Altman has been instrumental in the development of “truly robust guidelines for the reporting of clinical trials and wider clinical research studies,” noted GSK’s Global Head of Epidemiology Dr. Andrew Roddam, who presented the award on behalf of the sponsors.
Dr Fiona Godlee, Editor-in-chief of the The BMJ, said Professor Altman “has done more than anyone else to encourage researchers to fully report what they actually did, warts and all, rather than letting the best be the enemy of the good or, worse, pretending that research is perfect.”
Click here for the full release about the BMJ award winners.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
